Published in Korean J Hepatobiliary Pancreat Surg on August 31, 2013
Outcomes after curative resections of cholangiocarcinoma. Arch Surg (1993) 2.26
Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma. J Surg Oncol (2007) 1.81
Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer (2005) 1.70
Major hepatectomy with simultaneous pancreatectomy for advanced hepatobiliary cancer. J Am Coll Surg (2004) 1.58
Clinicopathologic factors influencing survival of patients with bile duct carcinoma: multivariate statistical analysis. World J Surg (1994) 1.33
Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins. Surgery (2005) 1.32
Treatment strategy for patients with middle and lower third bile duct cancer. Br J Surg (2001) 1.22
Role of nodal involvement and the periductal soft-tissue margin in middle and distal bile duct cancer. Ann Surg (1999) 1.15
Pathological appraisal of lines of resection for bile duct carcinoma. Br J Surg (2002) 1.12
Positive microscopic margins alter outcome in lymph node-negative cholangiocarcinoma when resection is combined with adjuvant radiotherapy. Am J Clin Oncol (2005) 1.00
The role of adjuvant radiotherapy in microscopic tumor control after extrahepatic bile duct cancer surgery. Am J Clin Oncol (2007) 0.97
Indication of hepatopancreatoduodenectomy for biliary tract cancer. World J Surg (2006) 0.85
Two-staged pancreatoduodenectomy with external drainage of pancreatic juice and omental graft technique. J Am Coll Surg (1998) 0.83
Procedure of extended hilar bile duct resection and its application for hilar cholangiocarcinoma. Hepatogastroenterology (2002) 0.80
Extended extrahepatic bile duct resection to avoid performing pancreatoduodenectomy in patients with mid bile duct cancer. Dig Surg (2008) 0.80
Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living donations safe. Liver Transpl (2006) 2.58
Restoration of portal flow using a pericholedochal varix in adult living donor liver transplantation for patients with total portosplenomesenteric thrombosis. Liver Transpl (2014) 1.66
Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma. Liver Transpl (2007) 1.59
The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation. Liver Transpl (2004) 1.41
Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations. Liver Transpl (2005) 1.27
Hepatectomy of living donors with a left-sided gallbladder and multiple combined anomalies for adult-to-adult living donor liver transplantation. Liver Transpl (2004) 1.21
Five-year follow-up of a hepatitis B virus-positive recipient of hepatitis B surface antigen-positive living donor liver graft. Liver Transpl (2006) 1.14
Long-term incidence, risk factors, and management of biliary complications after adult living donor liver transplantation. Liver Transpl (2006) 1.06
Liver transplantation and conventional surgery for advanced hepatocellular carcinoma. Transpl Int (2010) 0.93
Reconstruction of inferior right hepatic veins in living donor liver transplantation using right liver grafts. Liver Transpl (2012) 0.93
Novel technique of implantation for reversed modified right lobe graft from a donor with situs inversus totalis: new challenge in adult living donor liver transplantation. Transpl Int (2013) 0.91
A clinical assessment of mycophenolate drug monitoring after liver transplantation. Clin Transplant (2010) 0.88
Hepatic vein anatomy of the medial segment for living donor liver transplantation using extended right lobe graft. Liver Transpl (2005) 0.88
Living donor liver transplantation. Curr Opin Organ Transplant (2014) 0.87
Prevention of hepatitis B recurrence after living donor liver transplantation: primary high-dose hepatitis B immunoglobulin monotherapy and rescue antiviral therapy. Liver Transpl (2008) 0.86
Reappraisal of plasmapheresis as a supportive measure in a patient with hepatic failure after major hepatectomy. Case Rep Gastroenterol (2007) 0.85
Side-to-end renoportal anastomosis using an externally stented polytetrafluoroethylene vascular graft for a patient with a phlebosclerotic portal vein and a large spontaneous splenorenal shunt. J Am Coll Surg (2011) 0.82
A comparative study regarding the effect of an intraperitoneal anti-adhesive agent application in left-liver living donors. Korean J Hepatobiliary Pancreat Surg (2014) 0.80
Technique and outcome of autologous portal Y-graft interposition for anomalous right portal veins in living donor liver transplantation. Liver Transpl (2009) 0.80
Technical modification of reno-portal anastomosis in living donor liver transplantation for patients with obliterated portal vein and large spontaneous splenorenal shunts. Hepatogastroenterology (2009) 0.80
Conjoined unification venoplasty for triple portal vein branches of right liver graft: a case report and technical refinement. Korean J Hepatobiliary Pancreat Surg (2016) 0.79
Fenestration of liver cysts in polycystic liver disease to improve quality of life: a case report and literature review. Korean J Hepatobiliary Pancreat Surg (2015) 0.79
Application of intraoperative cine-portogram to detect spontaneous portosystemic collaterals missed by intraoperative doppler exam in adult living donor liver transplantation. Liver Transpl (2007) 0.79
Continuous peritransplant assessment of consciousness using bispectral index monitoring for patients with fulminant hepatic failure undergoing urgent liver transplantation. Clin Transplant (2009) 0.78
A review of current status of living donor liver transplantation. Hepatobiliary Surg Nutr (2016) 0.77
Tailored long-term immunosuppressive regimen for adult liver transplant recipients with hepatocellular carcinoma. Korean J Hepatobiliary Pancreat Surg (2014) 0.77
Morphometric and simulation analyses of right hepatic vein reconstruction in adult living donor liver transplantation using right lobe grafts. Liver Transpl (2010) 0.77
Preoperative prognostic values of α-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) in patients with hepatocellular carcinoma for living donor liver transplantation. Hepatobiliary Surg Nutr (2016) 0.75
Therapeutic induction of hepatic atrophy for isolated injury of the right posterior sectoral duct following laparoscopic cholecystectomy. Korean J Hepatobiliary Pancreat Surg (2011) 0.75
Incidental gallbladder cancer after routine cholecystectomy: when should we suspect it preoperatively and what are predictors of patient survival? Ann Surg Treat Res (2016) 0.75
Liver retransplantation for adult recipients. Korean J Hepatobiliary Pancreat Surg (2013) 0.75
Intra-individual variability of mycophenolic acid concentration according to renal function in liver transplant recipients receiving mycophenolate monotherapy. Ann Hepatobiliary Pancreat Surg (2017) 0.75
Fibrin glue-infiltrating hemostasis for intractable bleeding from the liver or spleen during liver transplantation. Ann Hepatobiliary Pancreat Surg (2016) 0.75
Living donor liver transplantation for patients with alcoholic liver disease. Korean J Hepatobiliary Pancreat Surg (2013) 0.75
Long-term outcome of ischemic type biliary stricture after interventional treatment in liver living donors: a report of two cases. Korean J Hepatobiliary Pancreat Surg (2015) 0.75
Standardized surgical techniques for adult living donor liver transplantation using a modified right lobe graft: a video presentation from bench to reperfusion. Korean J Hepatobiliary Pancreat Surg (2016) 0.75
Assessment of right liver graft perfusion effectiveness between one and two-catheter infusion methods. Korean J Hepatobiliary Pancreat Surg (2014) 0.75
Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection. Clin Mol Hepatol (2016) 0.75
Outcomes for patients with HCV after liver transplantation in Korea: a multicenter study. Ann Surg Treat Res (2015) 0.75